NASDAQ
CRISPR Therapeutics AG (CRSP) has a current ratio of 13.32x as of Monday, May 25, 2026. This represents a 29.05% decrease compared to its 12-month average of 18.77x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.